Open access
Sep 2026
Engineered Mesenchymal Stem Cells Expressing CD::UPRT and TRAIL Exhibit Potent Anti-Tumor Effects in Glioblastoma Patient-Derived Organoids
These findings validate the multifaceted anti-tumor activity of BM03 in GBOs that retain clinically relevant tumor heterogeneity and provide organoid-based preclinical evidence supporting further in vivo evaluation of BM03 as an MSC-based targeted therapeutic strategy for GBM.
Do-kyeong Kim, Min-Gyoung Park, Junseong Park et al.
· Cells · 0 citations